A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00556712 · COMPLETED
Trial details
- NCT number
- NCT00556712
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2010-11-01
- Enrollment
- 889
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.